What can be done about resistance to antibiotics?
作者信息
Turnidge J
机构信息
Microbiology and Infectious Diseases, Women's and Children's Hospital, Adelaide, SA 5006, Australia.
出版信息
BMJ. 1998 Sep 5;317(7159):645-7. doi: 10.1136/bmj.317.7159.645.
Abstract
摘要
相似文献
1
What can be done about resistance to antibiotics?
BMJ. 1998 Sep 5;317(7159):645-7. doi: 10.1136/bmj.317.7159.645.
2
Containment of antibiotic resistance.
Science. 1998 Feb 20;279(5354):1153-4. doi: 10.1126/science.279.5354.1153.
3
HAIs: more education needed.
Nurs Manage. 2006 Apr;37(4):6. doi: 10.1097/00006247-200604000-00001.
4
Control of antimicrobial resistance: time for action. The essentials of control are already well known.
BMJ. 1998 Sep 5;317(7159):613-4. doi: 10.1136/bmj.317.7159.613.
5
[Prevention of resistance to antibiotics. A complex problem].
Presse Med. 1998 Jun;27 Suppl 3:3.
6
[Prevention of bacterial resistance to antibiotics (author's transl)].
Quad Sclavo Diagn. 1979 Jun;15 Suppl 1:444-58.
7
Bacteroides, other nosocomial bacteria, and antibiotics.
Ann Intern Med. 1971 Dec;75(6):974. doi: 10.7326/0003-4819-75-6-974_1.
8
[Antibiotics and iatrogenic infections].
Orv Hetil. 1966 Apr 10;107(15):690-3.
9
[Control in use of antibiotics for prevention of cross infections].
Nihon Naika Gakkai Zasshi. 1993 Aug 10;82(8):1155-9.
10
[Salmonellosis in man: aspects of public health].
Ann Ist Super Sanita. 1977;13(3):651-6.
引用本文的文献
1
Applying pharmacokinetic/pharmacodynamic measurements for linezolid in critically ill patients: optimizing efficacy and reducing resistance occurrence.
Eur J Clin Pharmacol. 2022 Aug;78(8):1301-1310. doi: 10.1007/s00228-022-03340-z. Epub 2022 May 25.
2
Do physician outcome judgments and judgment biases contribute to inappropriate use of treatments? Study protocol.
Implement Sci. 2007 Jun 7;2:18. doi: 10.1186/1748-5908-2-18.
3
A qualitative study of patients' perceptions of acute infective conjunctivitis.
Br J Gen Pract. 2003 Jan;53(486):36-41.
4
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.
Antimicrob Agents Chemother. 2001 Dec;45(12):3334-40. doi: 10.1128/AAC.45.12.3334-3340.2001.
5
Management of urinary tract infection in general practice: a cost-effectiveness analysis.
Br J Gen Pract. 2000 Aug;50(457):635-9.
6
Infection and antimicrobial prescribing control in the new millennium: nightmare or nirvana?
J Clin Pathol. 2000 Jan;53(1):66-70. doi: 10.1136/jcp.53.1.66.
本文引用的文献
1
Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis.
JAMA. 1998 Jun 3;279(21):1736-42. doi: 10.1001/jama.279.21.1736.
2
Medical consequences of antibiotic use in agriculture.
Science. 1998 Feb 13;279(5353):996-7. doi: 10.1126/science.279.5353.996.
3
A clinical score to reduce unnecessary antibiotic use in patients with sore throat.
CMAJ. 1998 Jan 13;158(1):75-83.
4
Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.
JAMA. 1998 Feb 4;279(5):365-70. doi: 10.1001/jama.279.5.365.
5
Antibiotic use in the Australian community, 1990-1995.
Med J Aust. 1997 Aug 4;167(3):124-7. doi: 10.5694/j.1326-5377.1997.tb138809.x.
6
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.
N Engl J Med. 1997 Aug 14;337(7):441-6. doi: 10.1056/NEJM199708143370701.
7
Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis.
Pediatr Infect Dis J. 1997 Jul;16(7):680-95. doi: 10.1097/00006454-199707000-00011.
8
Open randomised trial of prescribing strategies in managing sore throat.
BMJ. 1997 Mar 8;314(7082):722-7. doi: 10.1136/bmj.314.7082.722.
9
Monitoring and management of bacterial resistance to antimicrobial agents: a World Health Organization symposium. Geneva, Switzerland, 29 November-2 December, 1995.
Clin Infect Dis. 1997 Jan;24 Suppl 1:S1-176.
10
Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Australian Group on Antimicrobial Resistance (AGAR).
Med J Aust. 1996 Jan 15;164(2):68-71.
Zotero 插件